The findings, opinions, conclusions, and assertions contained in this consensus document
are those of the individual members of the Working Group. They do not necessarily represent …

Objective: To provide information on disease attributable to respiratory syncytial viral lower
respiratory tract infection (RSV LRI) and to quantify the morbidity associated with various risk …

Because of the advent of a new influenza A H1N1 strain, many countries have begun mass
immunisation programmes. Awareness of the background rates of possible adverse events …

Background: Infants born at 33 through 35 completed weeks of gestation (33-35GA) are at
risk for severe respiratory syncytial virus (RSV) infection, and palivizumab prophylaxis lowers …

Objective: To develop guidelines for the diagnosis and management of community-acquired
pediatric pneumonia. Options: Clinical assessment, radiography, laboratory testing, and …

Context.—Meningococcal polysaccharide vaccines are not used routinely in infants and
toddlers, the groups at highest risk of invasive disease, because of poor immunologic responses …

OBJECTIVES: To describe differences in patients hospitalized with respiratory syncytial
virus (RSV) lower respiratory tract infection (LRI) at nine Canadian tertiary care hospitals. In …

OBJECTIVES: To describe the clinical course of fatal cases of pertussis and identify predictors
of death at the time of presentation for medical care. METHODS: Case-control study of 16 …

This is a Brighton Collaboration Case Definition of the term “Vaccine Associated Enhanced
Disease” to be utilized in the evaluation of adverse events following immunization. The Case …

To assess the morbidity associated with the continued high levels of pertussis, we studied
all children .2 years of age who were admitted to the 11 Immunization Monitoring Program-…